These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 5450719)

  • 1. Problems in producing alloxan diabetes.
    Pemberton LB; Manax WG
    Surgery; 1970 Aug; 68(2):375-8. PubMed ID: 5450719
    [No Abstract]   [Full Text] [Related]  

  • 2. Suprarenal intraarterial infusion of alloxan and streptozotocin during balloon occlusion of the juxtarenal abdominal aorta: a simple technique for inducing diabetes mellitus in canines with reduced mortality.
    Salis AI; Peterson RG; Stecker MS; Patel NH; Willis LR; Galley P; Eclavea AC; Dreesen RG
    Acad Radiol; 2001 Jun; 8(6):473-7. PubMed ID: 11394539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improved means of reproducing alloxan diabetes in dogs].
    Bondarenko MF; Azarian GP; Bobkov IuI; Leont'eva GV
    Probl Endokrinol (Mosk); 1978; 24(6):82-4. PubMed ID: 724679
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemically induced (streptozotocin-alloxan) diabetes mellitus in dogs].
    Liu S; Wang W; Luo XM; Ye B
    Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):125-8. PubMed ID: 12212196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality and renal failure in the streptozocin-alloxan diabetic dog attributed to contamined alloxan preparations.
    Cutfield R; Albu DS; Chan IF; Moatamed F; Peric-Golia L; Wilson DE
    Horm Metab Res; 1984 Oct; 16(10):549-50. PubMed ID: 6500490
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of alloxan upon canine exocrine pancreatic secretion.
    Tiscornia OM; Janowitz HD; Dreiling DA
    Am J Gastroenterol; 1968 Apr; 49(4):328-40. PubMed ID: 5650746
    [No Abstract]   [Full Text] [Related]  

  • 7. A double balloon catheter technique for alloxan diabetogenesis in the dog.
    Wigness BD; Mauer SM; Rupp WM; Rohde TD; Steffes MW; Blackshear PJ; Rucker RD; Jeraj K; Buchwald H
    Surg Gynecol Obstet; 1982 Dec; 155(6):860-4. PubMed ID: 7147169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and study of experimental diabetes in mice with alloxan.
    Bhaveja UK; Aurora AL; Agarwal DS
    Indian J Pathol Microbiol; 1982 Jan; 25(1):1-5. PubMed ID: 7106904
    [No Abstract]   [Full Text] [Related]  

  • 9. [Morphology of the skeletal musculature in alloxan diabetes].
    Titova GP; Khotenashvili NV
    Biull Eksp Biol Med; 1988 Apr; 105(4):504-6. PubMed ID: 3359041
    [No Abstract]   [Full Text] [Related]  

  • 10. An ultrastructural study of the effect of a diabetogenic dose of alloxan on the secretory ameloblasts of the rat incisor.
    Karim AC
    Am J Anat; 1983 Jan; 166(1):83-98. PubMed ID: 6837481
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of allergic inflammatory response in the skin of alloxan-diabetic rats: relationship with reduced local mast cell numbers.
    de F Carvalho V; Campos LV; Farias-Filho FA; Florim LT; Barreto EO; Pirmez C; Savino W; Martins MA; e Silva PM
    Int Arch Allergy Immunol; 2008; 147(3):246-54. PubMed ID: 18594156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin.
    Bae SK; Kim JY; Yang SH; Kim JW; Kim T; Lee MG
    Life Sci; 2006 Apr; 78(20):2287-94. PubMed ID: 16288785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of the treatment of diabetes mellitus on the development of cardiac changes in alloxan diabetes].
    Pog'atsa G; Bihari-Varga M; Szinay G
    Orv Hetil; 1980 Jan; 121(2):91-4. PubMed ID: 6768045
    [No Abstract]   [Full Text] [Related]  

  • 14. Te effect of continuous low-level gamma radiation on alloxan-induced lethality in mice.
    Watson JA; Doolittle DP
    Radiat Res; 1967 Sep; 32(1):176-82. PubMed ID: 6053862
    [No Abstract]   [Full Text] [Related]  

  • 15. [Protection of the islet apparatus in experimental alloxan diabetes].
    Kudriashov BA; Pytel' IuA; Baskakova GM; Sokolova GA; Liapina LA
    Patol Fiziol Eksp Ter; 1982; (2):67-70. PubMed ID: 7045785
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of tissue alloxan uptake.
    Bekdik FC; Farmelant MH; Tyson I
    J Nucl Med; 1968 Jan; 9(1):31-4. PubMed ID: 5634412
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effect of saturated, monounsaturated, and polyunsaturated fatty acids on alloxan-induced diabetes mellitus.
    Suresh Y; Das UN
    Prostaglandins Leukot Essent Fatty Acids; 2006 Mar; 74(3):199-213. PubMed ID: 16412622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrastructural manifestations of early metabolic disorders in the myocardium of dogs with alloxan diabetes].
    Lebkova NP; Bondarenko MF; Kolesova OE; Azarian GP
    Biull Eksp Biol Med; 1980 May; 89(5):614-7. PubMed ID: 7397346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of lipid peroxidation parameters in dogs with alloxan diabetes.
    Vajdovich P; Gaál T; Szilágyi A
    Acta Physiol Hung; 1993; 81(4):317-26. PubMed ID: 8067247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal glucose uptake in normal, untreated and insulin-treated diabetic dogs.
    Alada AR; Falokun PO; Oyebola DD
    Afr J Med Med Sci; 2005 Jun; 34(2):147-56. PubMed ID: 16749339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.